<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Management of deceased organ donor*&lt;sup&gt;[1]&lt;/sup&gt;</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Management of deceased organ donor*<sup>[1]</sup></h1>
<div class="graphic"><div class="figure"><div class="ttl">Management of deceased organ donor*<sup>[1]</sup></div><div class="cntnt"><table cellspacing="0"><colgroup span="9" width="11%"></colgroup> <tbody> <tr> <td class="subtitle1_left" colspan="9">Monitoring and access</td> </tr> <tr> <td class="indent1" colspan="9"> <ul> <li>Monitor temperature, heart rate and rhythm, SpO<sub>2</sub>, blood pressure, mean arterial pressure, continuously; monitor urine output, serially.</li> </ul> </td> </tr> <tr> <td class="indent1" colspan="9"> <ul> <li>Insert two large bore intravenous lines. Consider inserting central venous catheter and/or PAC to monitor patient hemodynamics (placement of PAC is particularly important in patients with an ejection fraction &lt;45% or requiring high dose inotropic medication). Insert arterial line.</li> </ul> </td> </tr> <tr> <td class="indent1" colspan="9"> <ul> <li>Obtain echocardiogram for all potential donors. Repeat echocardiogram when patient has stabilized if initial echocardiogram shows significant cardiac dysfunction.</li> </ul> </td> </tr> <tr> <td class="indent1" colspan="9"> <ul> <li>Early flexible bronchoscopy for inspection and airway clearance.</li> </ul> </td> </tr> <tr> <td class="subtitle1_left" colspan="9">Electrolytes</td> </tr> <tr> <td class="indent1" colspan="9"> <ul> <li>Maintain serum Na &gt;135 and &lt;155 mEq/dL.</li> </ul> </td> </tr> <tr> <td class="indent1" colspan="9"> <ul> <li>Maintain serum K &gt;4 and &lt;5 mEq/dL.</li> </ul> </td> </tr> <tr> <td class="indent1" colspan="9"> <ul> <li>Assess serum Mg, Ca, PO<sub>4</sub> and replace as needed.</li> </ul> </td> </tr> <tr> <td class="indent1" colspan="9"> <ul> <li>Assess serum lactate and central or mixed venous oxygen saturation.</li> </ul> </td> </tr> <tr> <td class="indent1" colspan="9"> <ul> <li>Correct metabolic acidosis with Na bicarbonate and mild hyperventilation. Aim for arterial pH 7.35 to 7.45.</li> </ul> </td> </tr> <tr> <td class="subtitle1_left" colspan="9">Ventilation</td> </tr> <tr> <td class="indent1" colspan="9"><strong>Initial set-up</strong></td> </tr> <tr> <td class="indent2" colspan="9"> <ul> <li>Mode: Typically, volume control.</li> </ul> </td> </tr> <tr> <td class="indent2" colspan="9"> <ul> <li>Tidal volume: 6 to 8 mL/kg (use ideal predicted body weight<sup>¶</sup>).</li> </ul> </td> </tr> <tr> <td class="indent2" colspan="9"> <ul> <li>Respiratory rate: 8 to 16 breaths/minute.</li> </ul> </td> </tr> <tr> <td class="indent2" colspan="9"> <ul> <li>PEEP: 5 to 10 cm H<sub>2</sub>O.</li> </ul> </td> </tr> <tr> <td class="indent2" colspan="9"> <ul> <li>Initial FiO<sub>2</sub>: 100%<sup>Δ</sup>; after stabilization, titrate down to 40%, as tolerated.</li> </ul> </td> </tr> <tr> <td class="indent1" colspan="9"><strong>Adjustments to initial settings</strong></td> </tr> <tr> <td class="indent2" colspan="9"> <ul> <li>Adjust rate and tidal volume to maintain PaCO<sub>2</sub> 35 to 45 mmHg (4.67 to 6 kPa). Adjust tidal volume, pressure profile, and flow rate to keep peak airway pressure &lt;30 cm H<sub>2</sub>O.</li> </ul> </td> </tr> <tr> <td class="indent2" colspan="9"> <ul> <li>Titrate FiO<sub>2</sub> and PEEP in tandem according to the FiO<sub>2</sub>/PEEP combinations below to maintain pulse oxygen saturation &gt;95% or PaO<sub>2</sub> &gt;90 mmHg (12 kPa).</li> </ul> </td> </tr> <tr> <td class="subtitle1_left" colspan="9">Autonomic storm with hypertension</td> </tr> <tr> <td class="indent1" colspan="9"> <ul> <li>Note, autonomic storm is typically transient. Hypertension and tachycardia should be treated with short-acting agents (eg, esmolol).</li> </ul> </td> </tr> <tr> <td class="subtitle1_left" colspan="9">Goals for resuscitation</td> </tr> <tr> <td class="indent1" colspan="9"> <ul> <li>Normal core body temperature versus mild hypothermia.</li> </ul> </td> </tr> <tr> <td class="indent1" colspan="9"> <ul> <li>Mean arterial pressure ≥60 mmHg.</li> </ul> </td> </tr> <tr> <td class="indent1" colspan="9"> <ul> <li>CVP ≤12 mmHg.</li> </ul> </td> </tr> <tr> <td class="indent1" colspan="9"> <ul> <li>PAOP ≤12 mmHg.</li> </ul> </td> </tr> <tr> <td class="indent1" colspan="9"> <ul> <li>SVR 800 to 1200 dynes/second/cm<sup>5</sup>.</li> </ul> </td> </tr> <tr> <td class="indent1" colspan="9"> <ul> <li>Left ventricular stroke work index &gt;15.</li> </ul> </td> </tr> <tr> <td class="indent1" colspan="9"> <ul> <li>Dopamine dosage &lt;10 mcg/kg/minute.</li> </ul> </td> </tr> <tr> <td class="indent1" colspan="9"> <ul> <li>Urine output ≥1 mL/kg/hour.</li> </ul> </td> </tr> <tr> <td class="subtitle1_left" colspan="9">Volume resuscitation</td> </tr> <tr> <td class="indent1" colspan="9"> <ul> <li>Maintain euvolemia: Assess volume status based on urine output, MAP, CVP, PAOP, and/or dynamic measures (eg, PPV, SPV).</li> </ul> </td> </tr> <tr> <td class="indent1" colspan="9"> <ul> <li>Replete volume with isotonic crystalloids (eg, 0.9% saline, Lactated Ringer solution, Plasma-Lyte, Normosol).</li> </ul> </td> </tr> <tr> <td class="subtitle1_left" colspan="9">Hematologic management</td> </tr> <tr> <td class="indent1" colspan="9"> <ul> <li>Correct abnormal INR or PTT (eg, ≥1.5 times control) with fresh frozen plasma.</li> </ul> </td> </tr> <tr> <td class="indent1" colspan="9"> <ul> <li>Infuse packed RBC to maintain blood hemoglobin &gt;7 mg/dL. A higher pre-procurement hemoglobin may be needed depending on the planned procedure.</li> </ul> </td> </tr> <tr> <td class="subtitle1_left" colspan="9">Vasopressor and inotropic agents</td> </tr> <tr> <td class="indent1" colspan="9"> <ul> <li>After repletion of circulating volume, if MAP &lt;60 mmHg, assess whether cause of hypotension is decreased SVR or decreased cardiac output.</li> </ul> </td> </tr> <tr> <td class="indent2" colspan="9"> <ul style="list-style-type: disc;"> <li>Infuse arginine vasopressin as noted below for decreased SVR.</li> </ul> </td> </tr> <tr> <td class="indent2" colspan="9"> <ul style="list-style-type: disc;"> <li>If MAP remains &lt;60 mmHg and LVEF &gt;45%, add vasopressor agent (eg, norepinephrine, phenylephrine).</li> </ul> </td> </tr> <tr> <td class="indent2" colspan="9"> <ul style="list-style-type: disc;"> <li>If MAP remains &lt;60 mmHg and LVEF &lt;45%, add inotropic agent (eg, dobutamine, dopamine, epinephrine).</li> </ul> </td> </tr> <tr> <td class="subtitle1_left" colspan="9">Hormonal resuscitation</td> </tr> <tr> <td class="indent1" colspan="9"> <ul> <li>Arginine vasopressin: 1 unit bolus intravenously, followed by continuous infusion of 0.01 to 0.04 units/minute, adjusted to maintain MAP &gt;60 mmHg and urinary output 0.5 to 1 mL/kg per hour.</li> </ul> </td> </tr> <tr> <td class="indent1" colspan="9"> <ul> <li>Hydrocortisone 300 mg IV, then 100 mg every 8 hours.</li> </ul> </td> </tr> <tr> <td class="indent1" colspan="9"> <ul> <li>Insulin: There is no universally accepted insulin regimen. To achieve a target blood glucose range (120 to 180 mg/dL), avoid the use of glucose-containing intravenous fluids and administer insulin only when necessary.</li> </ul> </td> </tr> <tr> <td class="subtitle1_left" colspan="9">Renal replacement therapy</td> </tr> <tr> <td class="indent1" colspan="9"> <ul> <li>Continuous renal replacement therapy may be used to facilitate management of severe volume overload, metabolic acidosis, or hyperkalemia in patients with diuretic-refractory oliguric or anuric acute kidney injury.</li> </ul> </td> </tr> <tr> <td class="subtitle1_left" colspan="9">VTE/stress ulcer prevention</td> </tr> <tr> <td class="indent1" colspan="9"> <ul> <li>Low molecular weight heparin (eg, enoxaparin 40 mg SC every 12 hours) for donors with normal kidney function and without active bleeding <strong>OR</strong> low dose unfractionated heparin SC.</li> </ul> </td> </tr> <tr> <td class="indent1" colspan="9"> <ul> <li>Proton pump inhibitor enterally.</li> </ul> </td> </tr> <tr> <td class="subtitle1_left" colspan="9">Use these FiO<sub>2</sub>/PEEP combinations to achieve oxygenation goal:</td> </tr> <tr> <td class="indent1">FiO<sub>2</sub></td> <td class="centered">0.3</td> <td class="centered">0.4</td> <td class="centered">0.5</td> <td class="centered">0.6</td> <td class="centered">0.7</td> <td class="centered">0.8</td> <td class="centered">0.9</td> <td class="centered">1.0</td> </tr> <tr> <td class="indent1">PEEP</td> <td class="centered">5</td> <td class="centered">5 to 8</td> <td class="centered">8 to 10</td> <td class="centered">10</td> <td class="centered">10 to 14</td> <td class="centered">14</td> <td class="centered">14 to 18</td> <td class="centered">18 to 24</td> </tr> </tbody></table></div><div class="graphic_footnotes"><p>SpO<sub>2</sub>: pulse oxygen saturation; 
        PAC: pulmonary artery catheter; 
        Na: sodium; 
        K: potassium; 
        Mg: magnesium; 
        Ca: calcium; 
        PO<sub>4</sub>: phosphate; 
        PEEP: positive end expiratory pressure; 
        FiO<sub>2</sub>: inspired oxygen concentration; 
        PaCO<sub>2</sub>: arterial tension of carbon dioxide; 
        PaO<sub>2</sub>: arterial tension of oxygen; 
        CVP: central venous pressure; 
        SVR: systemic vascular resistance; 
        MAP: mean arterial pressure; 
        PAOP: pulmonary artery occlusion pressure; 
        PPV: pulse pressure variation; 
        SPV: systolic pressure variation; 
        INR: international normalized ratio; 
        PTT: partial thromboplastin time; 
        RBC: red blood cells; 
        LVEF: left ventricular ejection fraction; 
        VTE: venous thromboembolism; 
        SC: subcutaneous; 
        DVT: deep venous thrombosis.</p>
<p>* Refer to UpToDate discussion of management of a deceased organ donor.</p>
<p>¶ Refer to UpToDate calculator for predicted body weight for men and women.</p>
    
    Δ The initial set-up is used to screen for potential lung donation. A PaO<sub>2</sub>/FiO<sub>2</sub> ratio &gt;300 mmHg is considered the minimum acceptable oxygenation threshold for donation.</div><div class="graphic_reference">References:
    <ol>
<li>Copeland H, Hayanga JW, Neyrinck A, et al. Donor heart and lung procurement: A consensus statement. J Heart Lung Transplant 2020; 39:501.</li>
<li>Kotloff RM, Blosser S, Fulda GJ, et al. Management of the Potential Organ Donor in the ICU: Society of Critical Care Medicine/American College of Chest Physicians/Association of Organ Procurement Organizations Consensus Statement. Crit Care Med 2015; 43:1291.</li>
<li>Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000; 342:1301.</li>
</ol></div><div id="graphicVersion">Graphic 116847 Version 6.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
